መነሻATBPF • OTCMKTS
add
Antibe Therapeutics Ord Shs
የገበያ ዜና
ፋይናንስ
የገቢ መግለጫ
ገቢ
የተጣራ ገቢ
| (CAD) | ዲሴም 2023info | ከዓመት ዓመት ለውጥ |
|---|---|---|
ገቢ | — | — |
የሥራ ወጪ | 4.60 ሚ | -1.42% |
የተጣራ ገቢ | -4.21 ሚ | 2.39% |
የተጣራ የትርፍ ክልል | — | — |
ገቢ በሼር | -0.08 | 0.50% |
EBITDA | — | — |
ውጤታማ የግብር ተመን | — | — |
ቀሪ ሒሳብ ሉሆች
አጠቃላይ ንብረቶች
አጠቃላይ ተጠያቂነቶች
| (CAD) | ዲሴም 2023info | ከዓመት ዓመት ለውጥ |
|---|---|---|
ጥሬ ገንዘብና የአጭር ጊዜ መዋዕለ ንዋይ | 24.91 ሚ | -41.20% |
አጠቃላይ ንብረቶች | 56.36 ሚ | -23.56% |
አጠቃላይ ተጠያቂነቶች | 30.42 ሚ | -0.13% |
አጠቃላይ እሴት | 25.94 ሚ | — |
የሼሮቹ ብዛት | 52.67 ሚ | — |
የገበያ ዋጋ እና የተገለጸ ዋጋ | 0.44 | — |
የእሴቶች ተመላሽ | -19.71% | — |
የካፒታል ተመላሽ | -41.30% | — |
የገንዘብ ፍሰት
የተጣራ ዝርዝር ገንዘብ በጥሬ ገንዘብ
| (CAD) | ዲሴም 2023info | ከዓመት ዓመት ለውጥ |
|---|---|---|
የተጣራ ገቢ | -4.21 ሚ | 2.39% |
ከክወናዎች የተገኘ ጥሬ ገንዘብ | -3.84 ሚ | -6.66% |
ገንዘብ ከኢንቨስትመንት | 11.04 ሚ | 1,975.38% |
ገንዘብ ከፋይናንስ | — | — |
የተጣራ ዝርዝር ገንዘብ በጥሬ ገንዘብ | 7.20 ሚ | 334.09% |
ነፃ የገንዘብ ፍሰት | -2.47 ሚ | -2,419.13% |
ስለ
Antibe Therapeutics was a Toronto-based pharmaceutical company that develops pain and inflammation-reducing drugs based on gaseous mediator technology. Antibe was founded by John L. Wallace, also a co-founder of NicOx, the first company to develop drugs utilizing gaseous mediators. Founded in 2009, the company listed on the TSX Venture Exchange in 2013 and was moved to the Toronto Stock Exchange in November 2020. In 2015, Antibe acquired Citagenix, a distributor involved in regenerative medicine.
On June 1, 2020, the company announced positive results in the final Phase 2 trial of its first drug Otenaproxesul.
On March 29, 2021, the drug's Investigational New Drug application was cleared by the US Food and Drug Administration, allowing for human trials.
In May 2024 the company went bankrupt and its stock was delisted from the Toronto Stock Exchange. Wikipedia
የተመሰረተው
2009
ድህረገፅ
ሠራተኞች
11
